- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03356197
Epidemiology of Conjunctivitis in the Emergency Department
November 27, 2017 updated by: Instituto de Olhos de Goiania
Epidemiology of Conjunctivitis in the Emergency Department of a Reference Ophthalmological Hospital in Goiânia
Epidemiology of Conjunctivitis in the Emergency Department of a Reference Ophthalmological Hospital in Goiânia.
Study Overview
Status
Completed
Conditions
Detailed Description
The purpose of this study was to determine the epidemiology of ocular emergencies in a Reference Ophthalmological Hospital in Goiânia, with emphasis on acute infectious conjunctivitis, morbidity with a higher incidence in this Service.
It aims to delineate the main etiologies found among infectious conjunctivitis and to compare them with those found in several other reference services in Ophthalmology.
Study Type
Observational
Enrollment (Actual)
783
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Goiás
-
Goiânia, Goiás, Brazil, 74110120
- Instituto de Olhos de Goiania
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients who were submitted to a initial care in the Emergency Department performed by the Ophthalmology First Year Resident (R1) .
Description
Inclusion Criteria:
- All those patients who were submitted to a initial care performed by the First Year Resident (R1) of the Hospital and who were admitted during the period described.
Exclusion Criteria:
- The patients who were admitted in the Emergency Department outside this period
- The patients who were not attended by a First Year Resident (R1)
- The patients who did not have all the data filled in the medical record
- The patients who needed to return, being attended in the hospital more than once.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evaluation of the main etiologies of acute infectious conjunctivitis in the Emergency Department of a Reference Hospital in Goiânia.
Time Frame: 126 days
|
Through clinical diagnosis in the Emergency Department
|
126 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2017
Primary Completion (Actual)
September 3, 2017
Study Completion (Actual)
November 1, 2017
Study Registration Dates
First Submitted
November 19, 2017
First Submitted That Met QC Criteria
November 27, 2017
First Posted (Actual)
November 29, 2017
Study Record Updates
Last Update Posted (Actual)
November 29, 2017
Last Update Submitted That Met QC Criteria
November 27, 2017
Last Verified
November 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Conjuntivite ARVO 2018
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Conjunctivitis
-
ShireCompletedAcute Viral ConjunctivitisUnited States, Brazil
-
IVIEW Therapeutics Inc.CompletedAcute Bacterial ConjunctivitisChina
-
Bausch & Lomb IncorporatedCompletedAcute Bacterial Conjunctivitis
-
Bausch & Lomb IncorporatedCompletedAcute Bacterial Conjunctivitis
-
Azidus BrasilUnknownAcute Bacterial ConjunctivitisBrazil
-
Azidus BrasilUnknownEfficacy Maxinom® And Maxitrol® in Reducing The Signs And Symptoms Of Acute Bacterial ConjunctivitisBacterial Conjunctivitis | AcuteBrazil
-
ShireCompletedAcute Adenoviral ConjunctivitisUnited States, India
-
ShireTerminatedAcute Adenoviral ConjunctivitisUnited States
-
Rapid Pathogen ScreeningCompletedAdenoviral Conjunctivitis | Acute ConjunctivitisUnited States, Germany
-
SacshCompletedAcute Infectious Conjunctivitis (Disorder)United States